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The origin and function of Langerhans cells remained elusive
for many years after their discovery by Paul Langerhans in
1868. It was not until 1961 that an ultrastructural marker of
Langerhans cells in the form of a unique organelle was
described [1]. Subsequently, while conducting an electron-
microscope study of contact allergic reactions in humans [2],
Dr. Inga Silberberg-Sinakin and her colleagues noted
apposition of lymphocytes to Langerhans cells, suggesting a
role for Langerhans cells in immunologic reactions. This
paper summarizes an interview with Drs. Inga Silberberg-
Sinakin and Rudolf Baer early in 1988, discussing their
reminiscences concerning this seminal observation and its
implications for Langerhans cell research.
During her early studies of the topical application of
mercuric chloride in humans, Dr. Silberberg-Sinakin ob-
served that there was apposition of lymphocyte-like cells to
Langerhans cells in the epidermis of individuals with contact
allergic reactions but not of those individuals with irritant
reactions or of normal subjects [2]. She remembers that it was
a troublesome finding to evaluate because findings observed
on electron microscopy are difficult to statistically quantitate.
Therefore, she proceeded to study a variety of contact
allergens in humans [3] and to seek and exploit an animal
model [4]. In studies of guinea pigs sensitized to dinitro-
chlorobenzene (DNCB), subsequent passive transfer
experiments with a time-course analysis demonstrated
Langerhans cells in dermal lymphatics [5,6], a finding that
strengthened the interpretation of an immunologic role for
the Langerhans cell.
At that time, very little was known about the biologic
functions of the Langerhans cell. As background, Dr. Baer
recalled that as early as 1875, Ranvier speculated that
Langerhans cells were derived from lymphocytes. However,
subsequent informed opinion was that Langerhans cells were
effete melanocytes. Then it was recognized that Langerhans
cells could be identified by electron microscopy based on the
key feature of a distinctive cytoplasmic organelle [1], that the
cell membrane of Langerhans cells contained ATPase [7];
and that Langerhans cell granules were endocytotic
organelles [8].
Dr. Silberberg-Sinakin went on to say that the initial
recognition of the morphologic observations led her and her
collaborators at New York University School of Medicine
(Dr. Jeanette Thorbecke and Dr. Baer) to suggest that the
Langerhans cell was the potential antigen-presenting cell in
the skin that people had been seeking. Dr. Silberberg-Sinakin
added her perspective on the controversies involved in the
acceptance of this work. She stated that there was support
within the Department of Dermatology at New York
University School of Medicine and among immunologists
and cell biologists. Within the general dermatologic com-
munity, however, there was reluctance to accept this new
immunologic function of the Langerhans cell.
Both Dr. Silberberg-Sinakin and Dr. Baer went on to state
that the studies which involved the uptake of ferratin by
Langerhans cells and their migration through dermal lymph
vessels to the lymph node were not only of great importance
in elucidating the fate of antigens taken up in the epidermis
and how they migrate to the regional lymph nodes [9,10], but
also was the first work that showed a applicability to contact
allergy [11]. Although contact allergy has been a model for
studying the fate of many different kinds of antigens, it also
suggested that in delayed-type hypersensitivity, reactions in
general Langerhans cells could serve the same functions.
Presumably, larger molecules, such as tumor antigens and
microbial antigens such as viruses and fungal antigens, are
taken up by Langerhans cells [12]. This function also applies
to transplantation antigens, and it has been shown that
Langerhans cells play a role in graft rejection [13] in the skin.
Moreover, Langerhans cells could be target cells [14], and the
damaging effects could be caused by lymphocytes or immune
complexes plus complement [14]. In addition, certain
physical agents and substances are capable of depressing
the functional capacity of Langerhans cells [I5–19]; notably
ultraviolet A and ultraviolet B and the topical or systemic
administration of glucocorticosteroids [20]. There are also
different numbers of Langerhans cells in various skin sites.
Areas with diminished numbers of Langerhans cells are not
able to mount contact reactions [21].
After the observation that Langerhans cells were antigen-
bearing cells, Dr. Silberberg-Sinakin said that she and her
colleagues reviewed the literature on antigen-bearing or
antigen-presenting cells (such as indeterminant dendritic
cells, interdigitating reticular cells, follicular dendritic reti-
cular cells described by Nossal, and dendritic cells described
by Steinman and Cohn) in other organs such as lymph node,
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spleen, and thymus and postulated that some of these cells
could be relatives of each other and that knowledge of one
cell type may be applicable to others [22]. Dr. Baer
concurred that there have been developments in the role of
dendritic cells in other organs so that today one can talk
about a dendritic cell system. The dendritic cells in lymph
nodes, thymus, spleen, Kupffer’s cells in the liver, and veil
cells in the intestines, are all parts of a large system of
dendritic cells [22]. The question has arisen as to whether
some of these cells are derived from Langerhans cells. It has
been shown [23] that cultured Langerhans cells go through
certain maturational transformations and that they resemble
lymphoid dendritic cells, suggesting that the maturation of
stimulatory function within the dendritic cell lineage
represents an important control point in the induction phase
of cell-mediated immunity. Apparently, all of these dendritic
cells have the capacity to present antigens, and they are
much better at this than cells of the macrophage-monocytes
series, he added. Depending on the site in which these
dendritic cells are located, there are certain differences;
however, they are at poor phagocytes and good at pinocytosis
and endocytosis. What is termed processing antigens is
actually the endocytosis of these particles [24,25] followed
by processing them chemically and returning them to the
surface. The Langerhans cell is the foremost type of dendritic
cell involved in this function, he said.
Dr. Baer went on to say that, regarding clinical applica-
tion, there is now an increasing interest in aging, and that the
demonstration of the waning immunologic capacity of
human beings as they get older, at least in part, may be
due to fewer Langerhans cells. There seems to be a decrease
in Langerhans cells in older humans [26]. Moreover, there is
evidence that there is a difference in the number of
functioning Langerhans cells between young and old
mice [27].
Dr. Baer said that there were some very basic things that
are still in a primitive state of knowledge. For example, it is
not known whether Langerhans cells are one particular cell
line or whether there are different varieties with, perhaps,
different functions. An important development arising from
the Langerhans cell studies is that another dendritic cell has
been discovered known as the Thy 1þ cell. Although this cell
only has been found in mice to date [28–30], there is most
certainly an equivalent in human beings and in other species.
These Thy 1þ cells are important because they may be the
antigen-presenting cells for suppressor cells, in contrast to the
Iaþ Langerhans cells [31–33], which are the antigen-
presenting cells for CD4
þ T cells and for delayed-type
hypersensitivity.
Dr. Baer went on to say that after it became evident that
CD4
þ T cells were destroyed by the human immunodefi-
ciency virus (HIV), it was shown that the number of
epidermal Langerhans cells in cutaneous biopsy specimens
from patients with acquired immunodeficiency syndrome
(AIDS), AIDS-related complex (ARC), and high-risk patients
who had no evidence of AIDS or ARC [34], as assessed by
examination of Ia antigens and membrane ATPase, was
diminished. A possible reason for the observation that
Langerhans cells are effected in AIDS may be that Langerhans
cells also have the CD4 (T4) receptor [35,36]. The HIV virus
enters the T cells by attaching to the CD4 receptor [37,38],
suggesting that the virus also can enter the Langerhans cells
via this receptor. He concluded that a major impact of the
research on the Langerhans cell has been on the general
knowledge about the skin. This includes the recognition that
the skin is a major immunologic organ and the fact that the
Langerhans cell is one of the features that seems to make it so.
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